APA (7th ed.) Citation

Haist, M., Stege, H., Lang, B. M., Tsochataridou, A., Salzmann, M., Mohr, P., . . . Loquai, C. (2022). Response to first-line treatment with immune-checkpoint inhibitors in patients with advanced cutaneous squamous cell carcinoma: A multicenter, retrospective analysis from the German ADOReg registry. Cancers, 14(22), . https://doi.org/10.3390/cancers14225543

Chicago Style (17th ed.) Citation

Haist, Maximilian, et al. "Response to First-line Treatment with Immune-checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry." Cancers 14, no. 22 (2022). https://doi.org/10.3390/cancers14225543.

MLA (9th ed.) Citation

Haist, Maximilian, et al. "Response to First-line Treatment with Immune-checkpoint Inhibitors in Patients with Advanced Cutaneous Squamous Cell Carcinoma: A Multicenter, Retrospective Analysis from the German ADOReg Registry." Cancers, vol. 14, no. 22, 2022, https://doi.org/10.3390/cancers14225543.